Intrathecal chemotherapy
Related entities
Findings (27)
None
improvementPatients with CNS leukemia treated with intrathecal chemotherapy alone had significantly better 3-year overall survival compared to those who received intrathecal chemotherapy in combination with cran
Effect: improvement; 51% vs. 18%
None
improvementPatients with CNS leukemia treated with intrathecal chemotherapy alone had significantly better 3-year overall survival compared to those who received intrathecal chemotherapy in combination with cran
Effect: improvement; 51% vs. 18%
None
improvementPatients with CNS leukemia treated with intrathecal chemotherapy alone had significantly better 3-year overall survival compared to those who received intrathecal chemotherapy in combination with cran
Effect: improvement; 51% vs. 18%
None
improvementPatients with CNS leukemia treated with intrathecal chemotherapy alone had significantly better 3-year overall survival compared to those who received intrathecal chemotherapy in combination with cran
Effect: improvement; 51% vs. 18%
None
improvementPatients with CNS leukemia treated with intrathecal chemotherapy alone had significantly better 3-year overall survival compared to those who received intrathecal chemotherapy in combination with cran
Effect: improvement; 51% vs. 18%
None
improvementPatients with CNS leukemia treated with intrathecal chemotherapy alone had significantly better 3-year overall survival compared to those who received intrathecal chemotherapy in combination with cran
Effect: improvement; 51% vs. 18%
None
improvementPatients with CNS leukemia treated with intrathecal chemotherapy alone had significantly better 3-year overall survival compared to those who received intrathecal chemotherapy in combination with cran
Effect: improvement; 51% vs. 18%
None
improvementPatients with CNS leukemia treated with intrathecal chemotherapy alone had significantly better 3-year overall survival compared to those who received intrathecal chemotherapy in combination with cran
Effect: improvement; 51% vs. 18%
None
improvementPatients with CNS leukemia treated with intrathecal chemotherapy alone had significantly better 3-year overall survival compared to those who received intrathecal chemotherapy in combination with cran
Effect: improvement; 51% vs. 18%
None
improvementPatients with CNS leukemia treated with intrathecal chemotherapy alone had significantly better 3-year overall survival compared to those who received intrathecal chemotherapy in combination with cran
Effect: improvement; 51% vs. 18%
None
improvementPatients with CNS leukemia treated with intrathecal chemotherapy alone had significantly better 3-year overall survival compared to those who received intrathecal chemotherapy in combination with cran
Effect: improvement; 51% vs. 18%
None
improvementPatients with CNS leukemia treated with intrathecal chemotherapy alone had significantly better 3-year overall survival compared to those who received intrathecal chemotherapy in combination with cran
Effect: improvement; 51% vs. 18%
None
improvementPatients with CNS leukemia treated with intrathecal chemotherapy alone had significantly better 3-year overall survival compared to those who received intrathecal chemotherapy in combination with cran
Effect: improvement; 51% vs. 18%
None
improvementPatients with CNS leukemia treated with intrathecal chemotherapy alone had significantly better 3-year overall survival compared to those who received intrathecal chemotherapy in combination with cran
Effect: improvement; 51% vs. 18%
None
improvementPatients with CNS leukemia treated with intrathecal chemotherapy alone had significantly better 3-year overall survival compared to those who received intrathecal chemotherapy in combination with cran
Effect: improvement; 51% vs. 18%
None
improvementPatients with CNS leukemia treated with intrathecal chemotherapy alone had significantly better 3-year overall survival compared to those who received intrathecal chemotherapy in combination with cran
Effect: improvement; 51% vs. 18%
None
improvementPatients with CNS leukemia treated with intrathecal chemotherapy alone had significantly better 3-year overall survival compared to those who received intrathecal chemotherapy in combination with cran
Effect: improvement; 51% vs. 18%
None
improvementPatients with CNS leukemia treated with intrathecal chemotherapy alone had significantly better 3-year overall survival compared to those who received intrathecal chemotherapy in combination with cran
Effect: improvement; 51% vs. 18%
None
improvementPatients with CNS leukemia treated with intrathecal chemotherapy alone had significantly better 3-year overall survival compared to those who received intrathecal chemotherapy in combination with cran
Effect: improvement; 51% vs. 18%
None
improvementPatients with CNS leukemia treated with intrathecal chemotherapy alone had significantly better 3-year overall survival compared to those who received intrathecal chemotherapy in combination with cran
Effect: improvement; 51% vs. 18%
None
improvementPatients with CNS leukemia treated with intrathecal chemotherapy alone had significantly better 3-year overall survival compared to those who received intrathecal chemotherapy in combination with cran
Effect: improvement; 51% vs. 18%
None
improvementPatients with CNS leukemia treated with intrathecal chemotherapy alone had significantly better 3-year overall survival compared to those who received intrathecal chemotherapy in combination with cran
Effect: improvement; 51% vs. 18%
None
improvementPatients with CNS leukemia treated with intrathecal chemotherapy alone had significantly better 3-year overall survival compared to those who received intrathecal chemotherapy in combination with cran
Effect: improvement; 51% vs. 18%
None
improvementPatients with CNS leukemia treated with intrathecal chemotherapy alone had significantly better 3-year overall survival compared to those who received intrathecal chemotherapy in combination with cran
Effect: improvement; 51% vs. 18%
None
improvementPatients with CNS leukemia treated with intrathecal chemotherapy alone had significantly better 3-year overall survival compared to those who received intrathecal chemotherapy in combination with cran
Effect: improvement; 51% vs. 18%
None
improvementPatients with CNS leukemia treated with intrathecal chemotherapy alone had significantly better 3-year overall survival compared to those who received intrathecal chemotherapy in combination with cran
Effect: improvement; 51% vs. 18%
None
improvementPatients with CNS leukemia treated with intrathecal chemotherapy alone had significantly better 3-year overall survival compared to those who received intrathecal chemotherapy in combination with cran
Effect: improvement; 51% vs. 18%